Insulet Corporation to Present at the Leerink Swann Global Healthcare Conference
(firmenpresse) - BEDFORD, MA -- (Marketwire) -- 02/13/12 -- Insulet Corporation (NASDAQ: PODD), the leader in technology with its OmniPod® Insulin Management System, today announced the Company will participate in the Leerink Swann Global Healthcare Conference 2012 at the Waldorf Astoria in New York City. Management is scheduled to present an overview of the Company on Thursday, February 16 at 8:00 a.m. E.T.
During the presentation, material information concerning the Company, its operations, strategies and prospects may be discussed. To listen to an audio webcast of the presentation during the event, please visit: . A replay of the webcast will be available for 10 days after the initial presentation.
Insulet Corporation is an innovative medical device company dedicated to making the lives of people with diabetes easier. Through its OmniPod Insulin Management System, Insulet seeks to expand the use of among people with insulin-dependent diabetes. The OmniPod is a revolutionary and easy-to-use tubeless insulin pump that features just two parts and fully-automated cannula insertion. Founded in 2000, Insulet Corporation is based in Bedford, Mass. For more information, please visit: .
Contact:
Stephanie Marks for Insulet Corporation
212-843-0211
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 13.02.2012 - 10:44 Uhr
Sprache: Deutsch
News-ID 1082312
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
BEDFORD, MA
Phone:
Kategorie:
Healthcare
Anmerkungen:
Diese Pressemitteilung wurde bisher 96 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Insulet Corporation to Present at the Leerink Swann Global Healthcare Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von
Insulet Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
